Defensin-like protein P322 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Defensin-like protein P322 antibody; Probable protease inhibitor P322 antibody
Uniprot No.

Target Background

Protein Families
DEFL family, Protease inhibitor I18 (RTI/MTI-2) subfamily
Subcellular Location
Secreted.
Tissue Specificity
Tuber.

Q&A

What is Defensin-like protein P322 and what organism does it originate from?

Defensin-like protein P322 is a cysteine-rich antimicrobial peptide that belongs to the defensin-like (DEFL) family. It originates from Solanum tuberosum (potato) and is specifically expressed in tuber tissues . This protein is classified within the protease inhibitor I18 (RTI/MTI-2) subfamily and functions as a secreted protein. Like other defensins, P322 contains the characteristic six-cysteine motif that forms disulfide bonds critical to its three-dimensional structure and antimicrobial function .

How does Defensin-like protein P322 compare structurally to other defensins?

Defensin-like protein P322 shares the conserved structural features of the defensin family, particularly the signature six-cysteine motif that creates intramolecular disulfide bonds. While human defensins are categorized into α-defensins, β-defensins, and θ-defensins based on their disulfide bond patterns , plant defensins like P322 typically align more closely with the β-defensin structural family.

The structural comparison can be visualized in this table:

Defensin TypeCysteine PatternDisulfide ConnectivityTypical SizeRepresentative Members
α-defensin (human)6 cysteines1-6, 2-4, 3-529-35 aaHNP-1, HD-5
β-defensin (human)6 cysteines1-5, 2-4, 3-636-45 aahBD-1, hBD-2, hBD-3
Plant defensins (incl. P322)6-8 cysteinesSimilar to β-defensins45-54 aaP322, DmAMP1

Unlike some mammalian defensins that require processing from larger precursors, plant defensins like P322 typically undergo more direct processing from pre-proteins with signal peptides that direct them to secretory pathways .

What are the primary biological functions of Defensin-like protein P322?

Based on research on similar plant defensins, Defensin-like protein P322 likely serves multiple biological functions:

  • Antimicrobial activity: Like other defensins, P322 likely possesses broad-spectrum antimicrobial properties, particularly against fungi. This activity is typically sensitive to inorganic cation concentration .

  • Membrane interaction: Plant defensins often induce changes in microbial membranes, causing increased K+ efflux and Ca2+ uptake by interacting with specific membrane components such as sphingolipids and ergosterols .

  • Protease inhibition: As suggested by its classification in the protease inhibitor I18 subfamily, P322 may function as a protease inhibitor, providing protection against microbial proteases during infection .

  • Plant defense responses: In its native context, P322 likely contributes to innate immunity in potato tubers against potential pathogens, similar to how defensins in other species contribute to host defense against microbial invasion .

What detection methods are compatible with Defensin-like protein P322 antibody?

The Defensin-like protein P322 antibody has been validated primarily for Western blot (WB) applications . When using this antibody for Western blotting, researchers typically apply the following methodological considerations:

  • Sample preparation: Protein extraction from potato tissue requires specific buffers to maintain protein integrity. A recommended extraction buffer contains 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and protease inhibitor cocktail.

  • Dilution factor: A typical working dilution range of 1:500 to 1:1000 is recommended for Western blot applications based on similar antibody products .

  • Detection system: Secondary antibodies conjugated with HRP (horseradish peroxidase) are commonly used, followed by enhanced chemiluminescence (ECL) detection.

While immunohistochemistry (IHC) applications are theoretically possible, specific protocols for P322 antibody in IHC have not been extensively validated in the literature. Researchers interested in IHC applications should perform preliminary optimization experiments.

What are the validated storage conditions and stability parameters for the P322 antibody?

For optimal stability and performance of the Defensin-like protein P322 antibody, the following storage conditions are recommended:

  • Long-term storage: -20°C to -70°C for up to 12 months from date of receipt .

  • Working storage: After reconstitution, store at 2-8°C under sterile conditions for up to 1 month, or at -20°C to -70°C for up to 6 months .

  • Freeze-thaw cycles: Minimize freeze-thaw cycles by aliquoting the antibody upon first thaw. Generally, more than 5 freeze-thaw cycles significantly reduce antibody performance .

  • Buffer composition: The antibody is typically supplied in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative.

  • Reconstitution: If supplied in lyophilized form, reconstitute using sterile distilled water or the recommended buffer, and allow the reconstituted product to stand at room temperature for 20-30 minutes before use.

How can researchers validate the specificity of the Defensin-like protein P322 antibody?

To ensure the specificity of the Defensin-like protein P322 antibody, researchers should implement the following validation strategies:

  • Positive control: Use recombinant Defensin-like protein P322 as a positive control. Testing with decreasing amounts (e.g., 100 ng, 50 ng, 25 ng) can help establish detection sensitivity limits .

  • Negative controls:

    • Tissue samples from species not expressing P322

    • Use of isotype control antibodies

    • Pre-absorption of the antibody with recombinant P322 protein (which should eliminate specific binding)

  • Cross-reactivity assessment: Test against related defensin proteins from the same species and defensins from other plant species to evaluate potential cross-reactivity.

  • Knockout/knockdown validation: If available, use tissue samples from P322 knockout or knockdown plants to confirm antibody specificity.

  • Alternative detection method: Confirm protein expression using an alternative method such as mass spectrometry or a different antibody targeting another epitope of the same protein.

How can the Defensin-like protein P322 antibody be used to investigate plant innate immunity pathways?

The Defensin-like protein P322 antibody can serve as a valuable tool for investigating plant innate immunity through several methodological approaches:

  • Expression profiling during pathogen challenge:

    • Time-course experiments measuring P322 expression levels in response to fungal, bacterial, or viral pathogens

    • Comparison of expression in resistant versus susceptible potato varieties

    • Correlation analysis between P322 expression levels and disease resistance phenotypes

  • Subcellular localization studies:

    • Immunofluorescence microscopy to track P322 localization during infection

    • Co-localization with known defense-related proteins

    • Fractionation studies followed by Western blot to identify compartmentalization patterns

  • Signal transduction pathway analysis:

    • Investigating P322 expression in plants treated with defense signaling molecules (salicylic acid, jasmonic acid, ethylene)

    • Using the antibody in chromatin immunoprecipitation (ChIP) assays to identify transcription factors regulating P322

    • Co-immunoprecipitation to identify protein interactions within defense signaling cascades

  • Comparative studies across plant species:

    • Using the antibody to detect homologous defensins in related Solanaceae species

    • Correlating defensin expression with evolutionary patterns of pathogen resistance

This approach helps understand the regulatory mechanisms governing defensin expression in plants and provides insights into the broader plant innate immunity network, similar to how human defensin research has revealed connections between innate and adaptive immunity .

What experimental designs can optimize the study of Defensin-like protein P322's antimicrobial mechanisms?

To elucidate the antimicrobial mechanisms of Defensin-like protein P322, researchers should consider these methodological approaches:

  • Membrane permeabilization assays:

    • Liposome leakage assays using fluorescent dyes to measure membrane disruption

    • Atomic force microscopy to visualize membrane structural changes

    • Electrophysiological measurements to detect ion channel formation or disruption

  • Target identification studies:

    • Pull-down assays using biotinylated P322 to identify binding partners

    • Surface plasmon resonance to measure binding kinetics with potential targets

    • Yeast two-hybrid screening to identify protein-protein interactions

  • Structural biology approaches:

    • X-ray crystallography or NMR spectroscopy of P322 alone and in complex with targets

    • Site-directed mutagenesis of conserved cysteine residues followed by functional assays

    • Molecular dynamics simulations to predict interaction mechanisms

  • Microbial response analysis:

    • Transcriptomics of microbes exposed to P322 to identify stress responses

    • Resistance development studies through serial passage experiments

    • Analysis of P322 activity against microbial mutants lacking specific cellular components

These experimental designs parallel approaches used to study defensin mechanisms in mammalian systems, where researchers have identified membrane penetration, lipid II targeting, and other mechanisms of antimicrobial activity .

How can researchers investigate the post-translational modifications of Defensin-like protein P322?

The investigation of post-translational modifications (PTMs) of Defensin-like protein P322 requires specialized techniques that can be implemented with the aid of the P322 antibody:

  • Immunoprecipitation coupled with mass spectrometry:

    • Use the P322 antibody to isolate the protein from plant extracts

    • Analyze the immunoprecipitated protein by tandem mass spectrometry to identify PTMs

    • Compare PTM profiles between healthy and stressed/infected plants

  • Site-specific PTM antibodies:

    • Develop antibodies specific to predicted PTM sites (phosphorylation, glycosylation, etc.)

    • Use these in conjunction with the general P322 antibody to measure modification rates

  • 2D gel electrophoresis followed by Western blotting:

    • Separate proteins by both isoelectric point and molecular weight

    • Use P322 antibody to detect different protein species representing various PTM states

    • Analyze shifts in patterns following different treatments or stimuli

  • In vitro modification assays:

    • Incubate purified P322 with relevant modification enzymes

    • Use the antibody to immunoprecipitate modified protein for further analysis

    • Compare structural and functional properties of modified versus unmodified protein

Understanding PTMs is critical as they may regulate the antimicrobial potency, stability, and target specificity of defensins, similar to how human β-defensin activity is modulated by reduction of disulfide bonds in different physiological environments .

How does the structure-function relationship of Defensin-like protein P322 compare with human defensins?

Understanding the structure-function relationship between plant Defensin-like protein P322 and human defensins provides valuable insights for comparative immunology:

FeaturePlant Defensins (P322)Human Defensins (e.g., hBD-3)
Antimicrobial spectrumPrimarily antifungalBroad spectrum (bacterial, fungal, viral)
MechanismMembrane interaction via specific lipid bindingMultiple mechanisms (membrane disruption, lipid II binding)
RegulationPrimarily constitutive in storage tissuesBoth constitutive and inducible expression
ImmunomodulationLimited evidenceWell-established chemotactic and immune signaling roles
Cation sensitivityHighly sensitiveVariable (hBD-3 shows salt-resistant activity)
  • Evolutionary implications:

    • The conserved structural framework despite sequence divergence suggests selection pressure on maintaining defensin fold

    • Functional specialization (antifungal vs. antibacterial) likely reflects different pathogen pressures in plants versus animals

    • The immunomodulatory functions in human defensins represent an evolutionary adaptation to integrate innate and adaptive immunity

This comparative analysis helps identify core defensin features preserved across kingdoms while highlighting adaptations specific to plant or animal host defense systems.

What methodological approaches can be used to study Defensin-like protein P322's role in the broader plant defensin network?

To position Defensin-like protein P322 within the broader context of plant defensin networks, researchers should consider these methodological approaches:

  • Phylogenetic analysis:

    • Construction of comprehensive defensin family trees across plant species

    • Correlation of sequence conservation patterns with functional properties

    • Identification of P322 orthologs in related species for comparative studies

  • Expression correlation networks:

    • Transcriptome analysis to identify genes co-regulated with P322

    • Construction of gene regulatory networks using techniques like WGCNA (Weighted Gene Co-expression Network Analysis)

    • Integration of proteomics data to validate predicted protein-protein interactions

  • Functional redundancy and compensation studies:

    • CRISPR/Cas9-mediated knockout of P322 followed by analysis of other defensin expression patterns

    • Overexpression of P322 to assess feedback regulation of related defensins

    • Double/triple knockout studies to identify functional redundancy among defensin family members

  • Systems biology integration:

    • Multi-omics approaches combining transcriptomics, proteomics, and metabolomics

    • Mathematical modeling of defensin network dynamics during pathogen challenge

    • Machine learning approaches to predict defensin function based on sequence features

This network-based approach parallels research on human defensin networks, where multiple defensin isoforms provide complementary functions within the immune system, with each defensin potentially having specific roles dependent on microenvironment and targeted microbes .

How can researchers use Defensin-like protein P322 antibody to investigate cross-kingdom conservation of antimicrobial mechanisms?

The Defensin-like protein P322 antibody can facilitate comparative studies across plant and animal kingdoms to reveal conserved antimicrobial mechanisms:

  • Cross-reactivity screening:

    • Test whether the P322 antibody recognizes structurally similar defensins from other species

    • Use sequence alignment and structural prediction to identify potential cross-reactive epitopes

    • Develop a panel of defensin antibodies for comparative immunological studies

  • Heterologous expression systems:

    • Express P322 in mammalian cell lines and use the antibody to track localization and processing

    • Compare post-translational modifications of plant defensins expressed in animal cells

    • Evaluate functional conservation by testing plant defensin activity against human pathogens

  • Receptor binding studies:

    • Investigate whether P322 can interact with mammalian defensin receptors like CCR6

    • Use the antibody to block potential binding sites and assess functional consequences

    • Perform competition assays between plant and human defensins for common targets

  • Combinatorial antimicrobial assays:

    • Test synergy between plant and animal defensins against various pathogens

    • Use the antibody to detect potential complex formation between defensins from different kingdoms

    • Develop chimeric defensins combining structural elements from plant and animal origins

This cross-kingdom approach can reveal fundamental mechanisms of host-pathogen interactions conserved throughout evolution and may identify novel antimicrobial strategies with potential therapeutic applications .

What are the common technical challenges when using Defensin-like protein P322 antibody in immunoassays?

Researchers working with Defensin-like protein P322 antibody may encounter several technical challenges that require specific troubleshooting approaches:

  • Low signal intensity in Western blots:

    • Increase antibody concentration (try 1:250 instead of 1:500)

    • Extend primary antibody incubation time (overnight at 4°C)

    • Use enhanced chemiluminescence detection systems with higher sensitivity

    • Increase protein loading amount (50-100 μg total protein)

    • Consider using PVDF membranes instead of nitrocellulose for higher protein binding capacity

  • High background or non-specific binding:

    • Increase blocking time and concentration (5% BSA or milk for 2 hours)

    • Add 0.1-0.3% Tween-20 to washing and antibody dilution buffers

    • Pre-absorb the antibody with proteins from non-target species

    • Reduce primary antibody concentration and optimize incubation conditions

    • Include additional washing steps (minimum 5 washes of 5 minutes each)

  • Sample degradation issues:

    • Add protease inhibitor cocktail to all extraction buffers

    • Maintain cold chain throughout sample preparation

    • Consider adding reducing agents (e.g., DTT) if working under reducing conditions

    • Process samples immediately after collection or snap-freeze in liquid nitrogen

  • Cross-reactivity with related defensins:

    • Verify antibody specificity using recombinant P322 protein

    • Include appropriate controls (tissue not expressing P322)

    • Consider using competitive binding assays to confirm specificity

    • If needed, conduct pre-absorption with related defensin proteins

How can researchers optimize immunohistochemistry protocols for Defensin-like protein P322 detection in plant tissues?

Optimizing immunohistochemistry (IHC) protocols for Defensin-like protein P322 in plant tissues requires attention to several plant-specific factors:

  • Tissue fixation and processing:

    • Use 4% paraformaldehyde in PBS for 12-24 hours at 4°C

    • Consider adding 0.1% glutaraldehyde for improved ultrastructural preservation

    • Optimize dehydration steps to prevent tissue shrinkage (gradual ethanol series)

    • Use plant-specific embedding media that adequately penetrate cell walls

    • Cut thin sections (5-8 μm) to ensure antibody penetration

  • Antigen retrieval methods:

    • Heat-induced epitope retrieval: Citrate buffer (pH 6.0) at 95°C for 20-30 minutes

    • Enzymatic retrieval: Try proteinase K (10-20 μg/ml for 10-15 minutes at 37°C)

    • For recalcitrant tissues, combine heat and enzymatic treatments

    • Include a cell wall digestion step using cellulase and pectinase

  • Blocking and antibody incubation:

    • Block with 5% normal serum + 1% BSA + 0.3% Triton X-100 for 2 hours

    • Extended primary antibody incubation (24-48 hours at 4°C)

    • Use antibody dilutions of 1:50 to 1:200 for initial optimization

    • Include 0.05% Tween-20 in all washing steps

    • Consider tyramide signal amplification for low-abundance targets

  • Plant-specific controls:

    • Include tissue from P322-deficient plants as negative controls

    • Use pre-immune serum as an additional control

    • Perform peptide competition assays to confirm specificity

    • Include counterstains to visualize plant cell walls (calcofluor white) and nuclei (DAPI)

  • Detection optimization:

    • Test both chromogenic (DAB) and fluorescent detection systems

    • For fluorescence, use secondary antibodies with longer wavelengths to avoid plant autofluorescence

    • Consider specialized mounting media containing antifade reagents

    • Image using confocal microscopy to improve signal-to-noise ratio

What considerations should researchers take when developing quantitative assays for Defensin-like protein P322?

Developing reliable quantitative assays for Defensin-like protein P322 requires attention to several methodological considerations:

  • Standard curve preparation:

    • Use recombinant P322 protein of known concentration

    • Prepare fresh standards for each assay

    • Include at least 7-8 concentration points in duplicate or triplicate

    • Ensure standards and samples are processed identically

  • ELISA development considerations:

    • Optimize coating buffer (carbonate buffer pH 9.6 recommended)

    • Determine optimal capture and detection antibody concentrations

    • Test different blocking agents (BSA, milk, commercial blockers)

    • Validate assay range, limit of detection, and precision

    • Consider sandwich ELISA using two different antibodies recognizing distinct epitopes

  • Western blot quantification:

    • Include internal loading controls (housekeeping proteins)

    • Use fluorescent secondary antibodies for wider dynamic range

    • Capture images within the linear range of detection

    • Analyze band intensities using appropriate software (ImageJ, etc.)

    • Run a standard curve on each gel for absolute quantification

  • Normalization strategies:

    • For plant tissues, normalize to total protein content

    • Consider tissue-specific reference genes for qPCR validation

    • Account for extraction efficiency using spike-in controls

    • Report results in standardized units (ng/mg total protein)

  • Method validation parameters:

    • Accuracy: Recovery of spiked recombinant P322 (aim for 80-120%)

    • Precision: Intra-assay CV <10%, inter-assay CV <15%

    • Specificity: No interference from related defensins

    • Linearity: R² >0.98 across working range

    • Robustness: Minimal variation with small changes in protocol parameters

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.